Sale!

Trevia R2 50mg+100mg Tablets – Ertugliflozin + Sitagliptin

Original price was: ₨ 552.Current price is: ₨ 530.

Brand Name: Trevia R2

Generic Names: Ertugliflozin + Sitagliptin

Manufacturer: Getz Pharmaceuticals

Packing: 14 Tablets

Description and Usage:

Trevia R2 is a fixed-dose combination of two antidiabetic medications:

  1. Ertugliflozin: Ertugliflozin is a sodium-glucose co-transporter 2 (SGLT2) inhibitor. It works by blocking the SGLT2 protein in the kidneys, which is responsible for reabsorbing glucose back into the bloodstream. By inhibiting SGLT2, Ertugliflozin promotes the excretion of glucose through the urine, leading to a reduction in blood sugar levels.
  2. Sitagliptin: Sitagliptin, as mentioned earlier, belongs to the class of dipeptidyl peptidase-4 (DPP-4) inhibitors. It increases the levels of active incretin hormones, which stimulate insulin release and lower blood sugar levels after meals.

Trevia R2 (Ertugliflozin + Sitagliptin) 5mg + 100mg tablets are prescribed for the management of type 2 diabetes mellitus in adults.

Category:

Description

As the search for effective diabetes management continues, medical science has achieved a remarkable milestone with the introduction of Trevia R2 50mg+100mg Tablets – Ertugliflozin + Sitagliptin.

This revolutionary combination medicine has garnered immense attention and is now easily accessible through e-commerce platforms, offering hope and relief to millions of diabetes patients worldwide.

Understanding Trevia R2 50mg+100mg Tablets :

Trevia R2 50mg+100mg Tablets are a groundbreaking medication that combines two active ingredients: Ertugliflozin and Sitagliptin.

Each tablet contains 5mg of Ertugliflozin and 100mg of Sitagliptin, making it a potent and effective tool in managing type 2 diabetes mellitus.

Ertugliflozin:

Ertugliflozin belongs to the class of medications known as sodium-glucose co-transporter 2 (SGLT2) inhibitors.

This compound acts by inhibiting SGLT2 in the kidneys, responsible for glucose reabsorption.

By doing so, Ertugliflozin helps the kidneys excrete excess glucose through urine, reducing blood sugar levels in individuals with type 2 diabetes.

Additionally, it has shown benefits in promoting weight loss and lowering blood pressure, making it an ideal option for diabetes patients with obesity and hypertension.

Sitagliptin:

Sitagliptin, on the other hand, is a dipeptidyl peptidase-4 (DPP-4) inhibitor.

DPP-4 is an enzyme that breaks down incretin hormones responsible for increasing insulin release and decreasing glucagon secretion.

By inhibiting DPP-4, Sitagliptin prolongs the action of these incretin hormones,

leading to enhanced insulin production when blood glucose levels are high, and reduced glucagon secretion, thereby decreasing glucose production by the liver.

The Synergistic Effect:

The combination of Ertugliflozin and Sitagliptin in Trevia R2 presents a synergistic effect that complements the individual actions of both components.

By simultaneously targeting multiple pathways involved in glucose regulation,

this medication offers a powerful and comprehensive approach to diabetes management, leading to improved glycemic control.

Advantages of Trevia R2:

Effective Glycemic Control:

Trevia R2 50mg+100mg Tablets have demonstrated superior efficacy in reducing HbA1c levels compared to individual monotherapies of Ertugliflozin or Sitagliptin.

Cardiovascular Benefits:

Clinical studies have shown that Ertugliflozin, as an SGLT2 inhibitor, may reduce the risk of cardiovascular events, such as heart attacks and strokes,

making Trevia R2 50mg+100mg Tablets a favorable choice for diabetic patients with cardiovascular risks.

Weight Loss:

The SGLT2 inhibitory action of Ertugliflozin contributes to weight loss, which is particularly beneficial for Higher Body Mass diabetes patients.

Convenience:

Combining two medications in a single tablet simplifies the treatment regimen for patients, potentially leading to better adherence.

Accessibility through E-commerce:

E-commerce platforms have revolutionized the way we access healthcare products,

providing convenience and accessibility to medications likeTrevia R2 50mg+100mg Tablets.

People living in remote areas or with limited access to physical pharmacies can now conveniently purchase this breakthrough medicine online and have it delivered to their doorstep.

It is essential to exercise caution while purchasing medications online.

Always ensure that you buy from reputable and licensed e-commerce platforms to avoid counterfeit products or potential risks to your health.

Conclusion:

Trevia R2 50mg+100mg Tablets – Ertugliflozin + Sitagliptin represent a significant step forward in diabetes management,

offering a potent and convenient option for patients striving to achieve better glycemic control.

With the convenience of e-commerce, this groundbreaking medication becomes more accessible to individuals worldwide,

empowering them to take charge of their health and lead fulfilling lives despite diabetes.

However, it is crucial to consult with a healthcare professional before starting any new medication to ensure it is suitable for your specific condition and medical history.

Buy: Vilget (Vildagliptin) 50mg Tablets

Reviews

There are no reviews yet.

Be the first to review “Trevia R2 50mg+100mg Tablets – Ertugliflozin + Sitagliptin”

Your email address will not be published. Required fields are marked *